Display options
Share it on

J Asthma Allergy. 2017 May 18;10:181-189. doi: 10.2147/JAA.S124902. eCollection 2017.

Asthma-like airway inflammation and responses in a rat model of atopic dermatitis induced by neonatal capsaicin treatment.

Journal of asthma and allergy

Rafael Taeho Han, Sewon Kim, Kyungmin Choi, Hyeonseok Jwa, JaeHee Lee, Hye Young Kim, Hee Jin Kim, Hang-Rae Kim, Seung Keun Back, Heung Sik Na

Affiliations

  1. Neuroscience Research Institute.
  2. Department of Physiology.
  3. Department of Microbiology, College of Medicine, Korea University, Seoul.
  4. Division of Biological Science and Technology, Science and Technology College, Yonsei University Wonju Campus, Wonju.
  5. Department of Anatomy, College of Medicine, Seoul National University, Seoul.
  6. Department of Pharmaceutics and Biotechnology, College of Medical Engineering, Konyang University, Chungnam, South Korea.

PMID: 28572736 PMCID: PMC5441677 DOI: 10.2147/JAA.S124902

Abstract

Recent studies have shown that approximately 70% of patients with severe atopic dermatitis (AD) develop asthma. Development of AD in infancy and subsequent other atopic diseases such as asthma in childhood is referred to as atopic march. However, a causal link between the diseases of atopic march has remained largely unaddressed, possibly due to lack of a proper animal model. Recently, we developed an AD rat model showing chronically relapsing dermatitis and scratching behaviors induced by neonatal capsaicin treatment. Here, we investigated whether our model also showed asthmatic changes, with the aim of expanding our AD model into an atopic march model. First, we confirmed that capsaicin treatment (50 mg/kg within 24 h after birth) induced dermatitis and scratching behaviors until 6 weeks of age. After that, the mRNA expression of Th1 and Th2 cytokines, such as IFN-γ and TNF-α, and IL-4, IL-5, and IL-13, respectively, was quantified with quantitative real-time polymerase chain reaction in the skin and the lungs. The number of total cells and eosinophils was counted in bronchoalveolar lavage (BAL) fluid. The levels of IgE in the serum and BAL fluid were determined with enzyme-linked immunosorbent assay. Paraffin-embedded sections (4 μm) were stained with hematoxylin/eosin to analyze the morphology of the lung and the airway. Airway responsiveness was measured in terms of airway resistance and compliance using the flexiVent system. In the capsaicin-treated rats, persistent dermatitis developed, and scratching behaviors increased over several weeks. The levels of IgE in the serum and BAL fluid as well as the mRNA expression of Th2 cytokines, including IL-4, IL-5, and IL-13, in both the skin and the lungs were elevated, and the number of eosinophils in the BAL fluid was also increased in the capsaicin-treated rats compared to control rats. Morphological analysis of the airway revealed smooth muscle hypertrophy and extensive mucus plug in the capsaicin-treated rats. Functional studies demonstrated an increment of the airway resistance and a decrement of lung compliance in the capsaicin-treated rats compared to control rats. Taken together, our findings suggested that neonatal capsaicin treatment induced asthma-like airway inflammation and responses in juvenile rats.

Keywords: BAL fluid; airway hypertrophy and remodelling; atopic march; cytokines; eosinophils; flexiVent; pruritus; scratching

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. J Clin Invest. 1998 Apr 15;101(8):1614-22 - PubMed
  2. Brain Res. 1998 Oct 5;807(1-2):147-54 - PubMed
  3. J Dermatol Sci. 2012 Aug;67(2):111-9 - PubMed
  4. Am J Respir Crit Care Med. 2003 May 15;167(10):1360-8 - PubMed
  5. Am J Respir Crit Care Med. 1997 Apr;155(4):1222-9 - PubMed
  6. Allergy. 1983 Nov;38(8):553-9 - PubMed
  7. Am Rev Respir Dis. 1992 Feb;145(2 Pt 2):S2-6 - PubMed
  8. Am J Respir Cell Mol Biol. 1999 Jun;20(6):1165-74 - PubMed
  9. Eur Respir J. 1997 Nov;10(11):2644-9 - PubMed
  10. Mucosal Immunol. 2016 Nov;9(6):1466-1476 - PubMed
  11. J Allergy Clin Immunol. 2003 Mar;111(3):450-63; quiz 464 - PubMed
  12. J Invest Dermatol. 2012 Apr;132(4):1169-76 - PubMed
  13. Br J Dermatol. 2004 Aug;151(2):335-45 - PubMed
  14. Immunol Res. 2006;35(3):219-32 - PubMed
  15. Am J Respir Crit Care Med. 2002 Jan 1;165(1):22-6 - PubMed
  16. J Allergy Clin Immunol. 1986 Apr;77(4):527-37 - PubMed
  17. Lancet. 2013 Oct 19;382(9901):1360-72 - PubMed
  18. Nat Med. 2002 Aug;8(8):885-9 - PubMed
  19. Am Rev Respir Dis. 1993 Aug;148(2):523-32 - PubMed
  20. J Clin Invest. 1999 Oct;104(7):829-35 - PubMed
  21. Eur J Immunol. 1998 Mar;28(3):769-79 - PubMed
  22. J Allergy Clin Immunol. 2003 Dec;112(6 Suppl):S118-27 - PubMed
  23. Physiology (Bethesda). 2005 Feb;20:28-35 - PubMed
  24. J Invest Dermatol. 2013 Jan;133(1):154-63 - PubMed
  25. Am J Respir Crit Care Med. 2004 May 1;169(9):1001-6 - PubMed
  26. Immunol Allergy Clin North Am. 2005 May;25(2):231-46, v - PubMed
  27. Thorax. 1988 Sep;43(9):684-92 - PubMed
  28. J Pediatr. 2010 Nov;157(5):704-14 - PubMed
  29. J Allergy Clin Immunol. 2003 Feb;111(2):215-25; quiz 226 - PubMed
  30. J Invest Dermatol. 2009 Mar;129(3):742-51 - PubMed

Publication Types